2018
DOI: 10.1371/journal.pone.0198256
|View full text |Cite
|
Sign up to set email alerts
|

The PKC-β selective inhibitor, Enzastaurin, impairs memory in middle-aged rats

Abstract: Enzastaurin is a Protein Kinase C-β selective inhibitor that was developed to treat cancers. Protein Kinase C-β is an important enzyme for a variety of neuronal functions; in particular, previous rodent studies have reported deficits in spatial and fear-conditioned learning and memory with lower levels of Protein Kinase C-β. Due to Enzastaurin’s mechanism of action, the present study investigated the consequences of Enzastaurin exposure on learning and memory in 12-month-old Fischer-344 male rats. Rats were tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Since PKCs-related pathways have been involved in the control of memory and learning processes, their role in cognitive disorders were investigated [43,44,45,46]. These cognitive disorders include Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Vascular Dementia, and Huntington Disease (HD).…”
Section: Protein Kinase Cs In Brain and Neurological Diseasesmentioning
confidence: 99%
“…Since PKCs-related pathways have been involved in the control of memory and learning processes, their role in cognitive disorders were investigated [43,44,45,46]. These cognitive disorders include Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Vascular Dementia, and Huntington Disease (HD).…”
Section: Protein Kinase Cs In Brain and Neurological Diseasesmentioning
confidence: 99%